Communiqués Algorae Pharmaceuticals Limited

Actions

1AI

AU0000296022

Recherche biotechnologique et médicale

Marché Fermé - Australian S.E. Autres places de cotation 07:30:20 06/08/2026			Varia. 5j.	Varia. 1 janv.
0,0110 ^AUD	-8,33%		-8,33%	-21,43%

15/07	Algorae Pharmaceuticals Limited annonce des changements au sein de son conseil d'administration, effectifs au 14 juillet 2026	CI
02/07	Algorae Pharmaceuticals Limited désignée fournisseur dans le cadre d'un contrat d'approvisionnement des hôpitaux publics de Nouvelle-Galles du Sud	CI

Communiqués

29/07/22	Living Cell Technologies : June Quarter 2022	PU
29/07/22	Living Cell Technologies : Quarterly Activity Report and Appendix 4C	PU
28/07/22	Living Cell Technologies : Change of Director's Interest Notice - B Tuch and A Kelly	PU
22/06/22	Living Cell Technologies : Investor Presentation - Gold Coast Investment Showcase	PU
03/06/22	Living Cell Technologies : Application for quotation of securities - LCT	PU
02/06/22	Living Cell Technologies : Quarterly Activity Report and Appendix 4C	PU
30/01/22	Living Cell Technologies : Quarterly Activity Report and Appendix 4C	PU
29/12/21	Living Cell Technologies : Update - Application for quotation of securities - LCT	PU
21/12/21	Living Cell Technologies : Update - Appendix 2A- Issue of shares and Options	PU
14/12/21	Living Cell Technologies : Application for quotation of securities - LCT	PU
12/12/21	Living Cell Technologies : Proposed issue of securities - LCT	PU
09/12/21	Living Cell Technologies : Update - Proposed issue of securities - LCT	PU
01/12/21	Living Cell Technologies : Appendix 2A- Issue of shares and Options	PU
29/11/21	Living Cell Technologies : Proposed issue of securities - LCT	PU
29/11/21	Living Cell Technologies : Chairman Presentation	PU
22/11/21	Living Cell Technologies : Non-Renounceable Rights Issue Opens	PU
15/11/21	Living Cell Technologies : Update - Proposed issue of securities - LCT	PU
14/11/21	Living Cell Technologies : Proposed issue of securities - LCT	PU
14/11/21	Living Cell Technologies : Prospectus- Rights Issue	PU
11/11/21	CEO's presentation to the AGM 2021	PU
11/11/21	CEO's presentation to AGM	PU
11/10/21	Living Cell Technologies : CEO's presentation to the AGM 2020	PU
30/01/20	Living Cell Technologies : Appendix 4C December Quarter 2019	PU
09/12/19	Living Cell Technologies : Response to Appendix 3Y Query	PU
08/11/19	Living Cell Technologies : Dr Andrew Kelly Joins LCT Board	PU